J&J named Namal Nawana as worldwide president of its orthopedics business, DePuy Synthes, in October.
The appointment put the former Smith & Nephew CEO in charge of leading DePuy during and after its separation from J&J.
Nawana will need to manage that process without the input of Storms. The departing executive said in a post published in late November that she was leaving J&J.
When J&J disclosed the spinout plan, analysts including Needham’s Mike Matson said DePuy’s rivals could initially benefit from the separation. Ultimately, though, the analysts expect the separation to strengthen DePuy.
Date: 5 January